Structure of Udenafil
CAS No.: 268203-93-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Udenafil is a PDE5 inhibitor used in urology to treat erectile dysfunction.
Synonyms: DA8159
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 268203-93-6 |
| Formula : | C25H36N6O4S |
| M.W : | 516.66 |
| SMILES Code : | O=S(C1=CC=C(OCCC)C(C2=NC3=C(N(C)N=C3CCC)C(N2)=O)=C1)(NCCC4N(C)CCC4)=O |
| Synonyms : |
DA8159
|
| MDL No. : | MFCD20275557 |
| InChI Key : | IYFNEFQTYQPVOC-UHFFFAOYSA-N |
| Pubchem ID : | 135413547 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H302-H315-H319-H335 |
| Precautionary Statements: | P261-P305+P351+P338 |
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT00767598 | Pharmacokinetics of Three PDE5... More >>Is Healthy Subjects Genetic Polymorphic CYP3A5 Less << | Phase 1 | Completed | - | - |
| NCT03430583 | - | Recruiting | December 31, 2020 | - | |
| NCT01232010 | Renal Insufficiency ... More >> Kidney Diseases Urologic Diseases Less << | Phase 1 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less << |
| NCT00282607 | Erectile Dysfunction | Phase 2 | Completed | - | United States, Alabama ... More >> Medical Affiliated Research Center Huntsville, Alabama, United States, 35801 United States, California The Male Clinic Beverly Hills, California, United States, 90212 South Orange County Laguna Woods, California, United States, 92653 California Profession Research Newport Beach, California, United States, 92660 West Coast Clinical Research Tarzana, California, United States, 91356 United States, Colorado Urology Research Options Aurora, Colorado, United States, 80012 United States, Connecticut Connecticut Clinical Research Center Waterbury, Connecticut, United States, 06708 United States, Florida South Florida Medical Research Aventura, Florida, United States, 33180 Florida Foundation for Healthcare Research Ocala, Florida, United States, 34474 United States, Indiana Northeast Indiana Research, LLC Fort Wayne, Indiana, United States, 46825 United States, Maryland Drs. Werner, Murdock & Francis, P.A. , Urology Associates Greenbelt, Maryland, United States, 20770 United States, New York Accumed Research Associates Garden City, New York, United States, 11530 Center for Urologic Research of Western New York Williamsville, New York, United States, 14221 United States, Rhode Island University Urological Researcgh Institute Providence, Rhode Island, United States, 02904 United States, Texas Urology San Antonio Research San Antonio, Texas, United States, 78229 Less << |
| NCT01065012 | Erectile Dysfunction | Phase 3 | Completed | - | - |
| NCT01940952 | Alzheimer's Disease | Phase 3 | Unknown | - | Korea, Republic of ... More >> Samguns Medical Center Not yet recruiting Seoul, Korea, Republic of, 135-710 Contact: Enda Go, Clinical Research Coordinator 82-2-3410-2868 ed.ko@samsung.com Principal Investigator: Duk L. Na, MD. PhD Less << |
| NCT01108900 | - | Completed | - | - | |
| NCT01037244 | Erectile Dysfunction | Phase 3 | Completed | - | - |
| NCT01037218 | Erectile Dysfunction | Phase 3 | Completed | - | - |
| NCT01037244 | - | Completed | - | - | |
| NCT01769482 | Microvascular Angina | Phase 4 | Unknown | December 2014 | Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of Contact: Dong-Ju Choi, M.D.,Ph.D. 82-31-787-7007 djchoi@snu.ac.kr Principal Investigator: Dong-Ju Choi, M.D.,Ph.D. Korea University Guro Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Eng-Ju Kim, M.D.,Ph.D. Principal Investigator: Eng-Ju Kim, M.D.,Ph.D. Less << |
| NCT01280266 | Raynaud Phenomenon | Phase 2 Phase 3 | Completed | - | Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less << |
| NCT01421940 | Rectal Cancer | Phase 4 | Completed | - | Korea, Republic of ... More >> Kyungpook National University Medical Center Daegu, Korea, Republic of, 702-210 Less << |
| NCT01305083 | Erectile Dysfunction | Phase 3 | Completed | - | Turkey ... More >> Ankara, Turkey, 06100 Ankara, Turkey Istanbul, Turkey Izmir, Turkey Mersin, Turkey, 33343 Less << |
| NCT01774864 | Erectile Dysfunction | Phase 3 | Completed | - | - |
| NCT01037218 | - | Completed | - | - | |
| NCT01280266 | - | Completed | - | - | |
| NCT01646515 | Systolic Heart Failure | Phase 3 | Terminated(Substantial benefit... More >> was observed in the active treatment group) Less << | - | Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less << |
| NCT01230541 | Spermatogenesis ... More >> Erectile Dysfunction Less << | Phase 1 | Completed | - | United States, Alabama ... More >> Warner Chilcott Investigational Site Huntsville, Alabama, United States, 35801 United States, California Warner Chilcott Investigational Site Anaheim, California, United States, 92801 Warner Chilcott Investigational Site San Diego, California, United States, 92103 Warner Chilcott Investigational Site San Diego, California, United States, 92120 Warner Chilcott Investigational Site Tarzana, California, United States, 91356 United States, Connecticut Warner Chilcott Investigational Site Middlebury, Connecticut, United States, 06762 United States, Florida Warner Chilcott Investigational Site Aventura, Florida, United States, 33180 Warner Chilcott Investigational Site Clearwater, Florida, United States, 33759 Warner Chilcott Investigational Site Doral, Florida, United States, 33166 Warner Chilcott Investigational Site Ocala, Florida, United States, 34474 Warner Chilcott Investigational Site Pinellas Park, Florida, United States, 33782 United States, Georgia Warner Chilcott Investigational Site Atlanta, Georgia, United States, 30342 United States, Louisiana Warner Chilcott Investigational Site Shreveport, Louisiana, United States, 71115 United States, New Jersey Warner Chilcott Investigational Site Plainsboro, New Jersey, United States, 08536 United States, New York Warner Chilcott Investigational Site Garden City, New York, United States, 11530 Warner Chilcott Investigational Site Great Neck, New York, United States, 11021 Warner Chilcott Investigational Site Purchase, New York, United States, 10577 Warner Chilcott Investigational Site Williamsville, New York, United States, 14221 United States, Ohio Warner Chilcott Investigational Site Cincinnati, Ohio, United States, 45212 United States, Texas Warner Chilcott Investigational Site San Antonio, Texas, United States, 78229 Warner Chilcott Investigational Site Webster, Texas, United States, 77598 United States, Virginia Warner Chilcott Investigational Site Norfolk, Virginia, United States, 23507 United States, Washington Warner Chilcott Investigational Site Spokane, Washington, United States, 99204 Less << |
| NCT01967251 | Erectile Dysfunction ... More >> Benign Prostatic Hyperplasia Less << | Phase 2 | Withdrawn | September 2016 | Mexico ... More >> Mexico, Distrito Federal, Mexico Mexico, Estado de México, Mexico Guadalajara, Jalisco, Mexico Morelia, Michoacán, Mexico Cuernavaca, Morelos, Mexico Monterrey, Nuevo León, Mexico Cholula, Puebla, Mexico Chihuahua, Mexico Less << |
| NCT01967264 | Erectile Dysfunction ... More >> Phosphodiesterase 5 Inhibitor Less << | Phase 1 | Completed | - | Mexico ... More >> Querétaro, Mexico Less << |
| NCT01901640 | Erectile Dysfunction | Phase 3 | Completed | - | - |
| NCT02741115 | Single Ventricle Heart Disease | Phase 3 | Active, not recruiting | March 2019 | - |
| NCT00607282 | Erectile Dysfunction|Sigmoid C... More >>olon Cancer|Rectal Cancer Less << | PHASE2 | COMPLETED | 2025-01-12 | Department of Surgery, Seoul N... More >>ational University Bundang Hospital, Seongnam, 463-707, Korea, Republic of Less << |
| NCT01553721 | Pulmonary Arterial Hypertensio... More >>n Less << | Phase 2 | Completed | - | Korea, Republic of ... More >> Seoul National University Hospital Seoul, Chongno-gu, 28 Yongon-dong, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Gangnam-Gu, Irwon-Dong 50, Korea, Republic of, 135-710 Severance Hospital, Yonsei University Health System Special City of Seoul, Seodaemungu, 250 Seonsanno, Korea, Republic of, 120-752 Chungbook national University Hospital Chung-ju, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwang-ju, Korea, Republic of Pusan national University Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of The catholic univ. of korea Seoul ST. MARY's hospital Seoul, Korea, Republic of Less << |
| NCT01231997 | Renal Insufficiency|Kidney Dis... More >>eases|Urologic Diseases Less << | PHASE1 | COMPLETED | - | Asan Medical Center, Seoul, Ko... More >>rea, Republic of Less << |
| NCT01929213 | Healthy Volunteers | Phase 1 | Unknown | February 2014 | Korea, Republic of ... More >> Severance Hospital Clinical Trial Center Seoul, Korea, Republic of Less << |
| NCT01241032 | Healthy Volunteers ... More >> Erectile Dysfunction Less << | Phase 1 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less << |
| NCT01599117 | Diastolic Heart Failure | Phase 3 | Unknown | May 2013 | Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Contact: Goo-Yeong Cho, MD, PhD 82-10-9870-9753 cardioch@snu.ac.kr Principal Investigator: Goo-Yeong Cho, MD, PhD Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Yong-Jin Kim, MD, PhD 82-10-3782-9382 kimdamas@snu.ac.kr Contact: In-Chang Hwang, MD 82-10-5113-2395 inchang.hwang@gmail.com Principal Investigator: Yong-Jin Kim, MD, PhD Sub-Investigator: Hyung-Kwan Kim, MD, PhD Sub-Investigator: Seung-Pyo Lee, MD Sub-Investigator: Kyung-Hee Kim, MD Sub-Investigator: Yeonyee E Yoon, MD Sub-Investigator: In-Chang Hwang, MD Less << |
| NCT03013751 | Functional Single Ventricle He... More >>art Disease Less << | PHASE3 | UNKNOWN | 2025-12-20 | Phoenix Children's Hospital/Ch... More >>ildren's Heart Center at Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|Cedars/Sinai Heart Institute, Los Angeles, California, 90048, United States|Rady Children's Hospital, San Diego, California, 92123, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Nemours Cardiac Center/Alfred I. duPont Hospital for Children, Wilmington, Delaware, 19803, United States|Children's National Medical Center, Washington, District of Columbia, 20008, United States|Johns Hopkins All Children's Heart Institute, Saint Petersburg, Florida, 33701, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30322, United States|Riley Hospital for Children/Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana, 46201, United States|Boston Children's Hospital, Boston, Massachusetts, 02115, United States|University of Michigan Congenital Heart Center/C.S. Mott Children's Hospital, Ann Arbor, Michigan, 48109-4204, United States|Children's Mercy Hospital Kansas City, Kansas City, Missouri, 64108, United States|Washington University St. Louis/St.Louis Children's Hospital, Saint Louis, Missouri, 63110, United States|Children's Hospital of New York, New York, New York, 10032, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Texas Children's Hospital, Houston, Texas, 77030, United States|Primary Children's Medical Hospital/Dept. of Pediatric Cardiology, Salt Lake City, Utah, 84113, United States|Seattle Children's Hosptial, Seattle, Washington, 98105, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, 53226, United States|The Hospital for Sick Children, Toronto, Ontario, ON M5G 1X8, Canada|Sejong General Hospital, Bucheon-si, Gyeonggi-do, 14754, Korea, Republic of|Seoul National University Children's Hospital, Seoul, 110-744, Korea, Republic of Less << |
| NCT02201342 | Single Ventricle Heart Disease... More >> After Fontan Surgery Less << | PHASE1|PHASE2 | COMPLETED | 2025-04-15 | Riley Hospital for Children, I... More >>ndianapolis, Indiana, 46201, United States|University of Michigan Congenital Heart Center, Ann Arbor, Michigan, 48109-4204, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Primary Children's Medical Center, Salt Lake City, Utah, 84113, United States|The Hospital for Sick Children, Toronto, Ontario, M5G1X8, Canada Less << |
| NCT01696240 | Mild Pulmonary Hypertension | Phase 3 | Unknown | December 2013 | Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Yong-Jin Kim, MD, PhD 82-10-3782-9382 kimdamas@snu.ac.kr Contact: Yeonyee Yoon, MD islandtea@gmail.com Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Yong-Jin Kim, MD, PhD 82-10-3782-9382 kimdamas@snu.ac.kr Contact: Yeonyee E Yoon, MD 82-31-787-7072 islandtea@gmail.com Less << |
| NCT01466543 | Vascular Dementia ... More >> Subcortical Vascular Dementia Less << | Phase 2 | Unknown | November 2012 | Korea, Republic of ... More >> Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 135-710 Contact: Hyunhee Jung, BSc 82-2-3410-6830 ext 6830 napapaya@hanmail.net Less << |
| NCT01364181 | Dyspnea|Chronic Obstructive Pu... More >>lmonary Disease|Pulmonary Hypertension Less << | PHASE3 | COMPLETED | 2025-05-11 | Seoul National University Bund... More >>ang Hospital, Seongnam, Gyeonggi-do, 463-707, Korea, Republic of Less << |
| NCT00956306 | Hepatic Impairment | PHASE1 | COMPLETED | 2025-09-12 | Seoul National University Hosp... More >>ital, Seoul, Korea, Republic of Less << |
| NCT02304198 | Pulmonary Arterial Hypertensio... More >>n Less << | PHASE2|PHASE3 | COMPLETED | 2025-02-16 | Samsung Medical Center, Seoul,... More >> Gangnam-Gu, Irwon-Dong 50, 135-710, Korea, Republic of Less << |
| NCT01928563 | Healthy Male Subjects | Phase 1 | Unknown | December 2013 | Korea, Republic of ... More >> Asan Medical Center Not yet recruiting Seoul, Songpa-gu, Korea, Republic of, 138-786 Contact: Kyun-Seop Bae, M.D., Ph.D. +82-2-3010-4611 ksbae@amc.seoul.kr Principal Investigator: Kyun-Seop Bae, M.D., Ph.D. Less << |
| NCT03142542 | Prostate Cancer With Radical P... More >>rostatectomy Less << | Phase 4 | Not yet recruiting | December 2019 | - |
Tags: Udenafil | DA8159 | Benzene Compounds | Pyrrolidines | PDE | Organic Building Blocks | Metabolic Enzyme | Wnt Signaling Pathway | Heterocyclic Building Blocks | 268203-93-6
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


